Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chaige Tuire oral liquid
- Development stage
- Unknown
- Lead developer
- Shanghai Yuzhihua Pharmaceutical Technology
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Chaige Tuire oral liquid is a Traditional Chinese Medicine (TCM) formulation developed by Shanghai Yuzhihua Pharmaceutical Technology Co., Ltd. for the treatment of acute upper respiratory tract infections and the common cold, specifically targeting wind-heat syndrome. The formulation is derived from traditional antipyretic prescriptions and typically includes extracts from *Bupleurum chinense* (Chai Hu) and *Pueraria lobata* (Ge Gen). Its therapeutic effects are attributed to its antipyretic, anti-inflammatory, and analgesic properties, which help reduce fever, alleviate headaches, and soothe sore throats. The drug works by modulating inflammatory pathways and the body's thermoregulatory responses. It has undergone Phase III clinical trials in China to evaluate its efficacy and safety in pediatric and adult populations.
- Other names
- Chaige Tuire Koufuye柴葛退热口服液
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Chaige Tuire oral liquid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chaige Tuire oral liquid.